title: Slow deactivation and U-shaped inactivation properties in cloned Cav1.2b channels in Chinese hamster ovary cells.
abstract: Whole-cell patch-clamp techniques were applied to Chinese hamster ovary cells stably expressing cloned smooth muscle Ca(2+) channel alpha(1)-subunits. In the presence of Ba(2+) as a charge carrier, U-shaped inactivation was observed in the presence and absence of Ca(2+) agonists. Also, tail currents deactivated slowly when conditioning steps of positive potential were applied. The deactivation time constant was decreased by hyperpolarizing the repolarization step. Application of ATP-gamma-S or H-7 had little effect on the conditions necessary to induce slow tail, suggesting involvement of physical processes in the channel protein. In the presence of Bay K 8644, additional application of nifedipine decreased the amplitudes of the test and tail currents induced by a test step preceded by a conditioning step to +80 mV, but did not affect the decay time constant of the tail current. From these results and assumptions we have drawn up a kinetic scheme with one closed state, two open states (O(1), O(2)) and two inactivated states linked to the closed state and open state O(1), respectively, i.e., open state O(2) protected from inactivation. Computer calculation reconstructed slow deactivation and U-shaped inactivation properties. A similar kinetic scheme with Ca(2+)-agonist-binding states accounted for the results in the presence of Ca(2+) agonists.
authors.affiliation: Department of Cell Physiology, Nagoya University Graduate School of Medicine, Japan.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Aoyama
authors.forename: Manabu
authors.initials: M
authors.lastname: Murakami
authors.forename: Toshihide
authors.initials: T
authors.lastname: Iwashita
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Ito
authors.forename: Kenichi
authors.initials: K
authors.lastname: Yamaki
authors.forename: Shinsuke
authors.initials: S
authors.lastname: Nakayama
mesh_terms: D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / Q000494:pharmacology; D000818:Animals; D001464:Barium / Q000494:pharmacology; D016466:CHO Cells / Q000502:physiology; D020746:Calcium Channels, L-Type / Q000187:drug effects* / Q000235:genetics / Q000502:physiology*; D003001:Cloning, Molecular; D003198:Computer Simulation; D006224:Cricetinae; D015640:Ion Channel Gating / Q000502:physiology*; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D008954:Models, Biological; D009130:Muscle, Smooth / Q000502:physiology*; D009543:Nifedipine / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D021122:Protein Subunits / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D011994:Recombinant Proteins / Q000187:drug effects / Q000378:metabolism
chemical_list: D020746:Calcium Channels, L-Type; C419385:L-type calcium channel alpha(1C); D021122:Protein Subunits; D011994:Recombinant Proteins; D001464:Barium; D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; D009543:Nifedipine